Otonomy to Host Key Opinion Leader Meeting for Investors on Ménière’s Disease

Back to Jobs

SAN DIEGO , June 20, 2017 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that it will host a Key Opinion Leader meeting on Ménière’s

Apply Now